Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1989 Jan 1;169(1):197–211. doi: 10.1084/jem.169.1.197

Inhibition of cellular DNA synthesis by reovirus occurs through a receptor-linked signaling pathway that is mimicked by antiidiotypic, antireceptor antibody

PMCID: PMC2189184  PMID: 2562847

Abstract

Mammalian reovirus type 3 binds to a 67-kD surface glycoprotein on the membrane of neuronal cells. This interaction initiates the infective reovirus cycle. The physiological function of this virus receptor is not known, however, initial studies illustrate a striking structural and antigenic homology to the beta adrenergic receptor family. The earliest known pathologic effect of reovirus type 3 is an inhibition of host cell DNA synthesis within 8-10 h after virus attachment. The studies reported here demonstrate that binding and aggregation of reovirus receptor molecules provides the signal for this inhibitory process. Inhibition of DNA synthesis in the neuroblastoma cell line B104.G4 was unaffected by using replication-defective virus or when lysosomal processing of normal virus was blocked. Inhibition was mimicked by an antiidiotypic, antireceptor mAb. Inhibition was not observed when monovalent mAb fragments were bound to receptors, but was reconstituted when these fragments were aggregated by the addition of anti-Ig. The signal for the inhibitory effect was generated within the first 60 min after mAb binding. These observations demonstrate that reovirus and antiidiotypic pathogenicity can result from the perturbation of membrane proteins that may perform normal physiological functions.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babiss L. E., Luftig R. B., Weatherbee J. A., Weihing R. R., Ray U. R., Fields B. N. Reovirus serotypes 1 and 3 differ in their in vitro association with microtubules. J Virol. 1979 Jun;30(3):863–874. doi: 10.1128/jvi.30.3.863-874.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bassel-Duby R., Nibert M. L., Homcy C. J., Fields B. N., Sawutz D. G. Evidence that the sigma 1 protein of reovirus serotype 3 is a multimer. J Virol. 1987 Jun;61(6):1834–1841. doi: 10.1128/jvi.61.6.1834-1841.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bidlack J. M., Mabie P. C. Preparation of Fab fragments from a mouse monoclonal IgM. J Immunol Methods. 1986 Jul 24;91(2):157–162. doi: 10.1016/0022-1759(86)90473-4. [DOI] [PubMed] [Google Scholar]
  4. Borsa J., Morash B. D., Sargent M. D., Copps T. P., Lievaart P. A., Szekely J. G. Two modes of entry of reovirus particles into L cells. J Gen Virol. 1979 Oct;45(1):161–170. doi: 10.1099/0022-1317-45-1-161. [DOI] [PubMed] [Google Scholar]
  5. Choi A. H., Lee P. W. Does the beta-adrenergic receptor function as a reovirus receptor? Virology. 1988 Mar;163(1):191–197. doi: 10.1016/0042-6822(88)90246-2. [DOI] [PubMed] [Google Scholar]
  6. Co M. S., Gaulton G. N., Fields B. N., Greene M. I. Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1494–1498. doi: 10.1073/pnas.82.5.1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Co M. S., Gaulton G. N., Tominaga A., Homcy C. J., Fields B. N., Greene M. I. Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5315–5318. doi: 10.1073/pnas.82.16.5315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cox D. C., Shaw J. E. Inhibition of the initiation of cellular DNA synthesis after reovirus infection. J Virol. 1974 Mar;13(3):760–761. doi: 10.1128/jvi.13.3.760-761.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dalgleish A. G., Beverley P. C., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984 Dec 20;312(5996):763–767. doi: 10.1038/312763a0. [DOI] [PubMed] [Google Scholar]
  10. Dower S. K., Ozato K., Segal D. M. The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding. J Immunol. 1984 Feb;132(2):751–758. [PubMed] [Google Scholar]
  11. Drayna D., Fields B. N. Genetic studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol. 1982 Nov;63(Pt 1):149–159. doi: 10.1099/0022-1317-63-1-149. [DOI] [PubMed] [Google Scholar]
  12. Ensminger W. D., Tamm I. Inhibition of synchronized cellular deoxyribonucleic acid synthesis during Newcastle disease virus, mengovirus, or reovirus infection. J Virol. 1970 Jun;5(6):672–676. doi: 10.1128/jvi.5.6.672-676.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ensminger W. D., Tamm I. The step in cellular DNA synthesis blocked by reovirus infection. Virology. 1969 Dec;39(4):935–938. doi: 10.1016/0042-6822(69)90032-4. [DOI] [PubMed] [Google Scholar]
  14. Finberg R., Weiner H. L., Fields B. N., Benacerraf B., Burakoff S. J. Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A. 1979 Jan;76(1):442–446. doi: 10.1073/pnas.76.1.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fontana A., Weiner H. L. Interaction of reovirus with cell surface receptors. II. Generation of suppressor T cells by the hemagglutinin of reovirus type 3. J Immunol. 1980 Dec;125(6):2660–2664. [PubMed] [Google Scholar]
  16. GOMATOS P. J., TAMM I. MACROMOLECULAR SYNTHESIS IN REOVIRUS-INFECTED L CELLS. Biochim Biophys Acta. 1963 Aug 20;72:651–653. [PubMed] [Google Scholar]
  17. Gaulton G. N., Greene M. I. Idiotypic mimicry of biological receptors. Annu Rev Immunol. 1986;4:253–280. doi: 10.1146/annurev.iy.04.040186.001345. [DOI] [PubMed] [Google Scholar]
  18. Gaulton G. N., Sharpe A. H., Chang D. W., Fields B. N., Greene M. I. Syngeneic monoclonal internal image anti-idiotopes as prophylactic vaccines. J Immunol. 1986 Nov 1;137(9):2930–2936. [PubMed] [Google Scholar]
  19. Gaulton G., Co M. S., Greene M. I. Anti-idiotypic antibody identifies the cellular receptor of reovirus type 3. J Cell Biochem. 1985;28(1):69–78. doi: 10.1002/jcb.240280110. [DOI] [PubMed] [Google Scholar]
  20. Hand R., Ensminger W. D., Tamm I. Cellular DNA replication in infections with cytocidal RNA viruses. Virology. 1971 Jun;44(3):527–536. doi: 10.1016/0042-6822(71)90366-7. [DOI] [PubMed] [Google Scholar]
  21. Hand R., Tamm I. Initiation of DNA replication in mammalian cells and its inhibition by reovirus infection. J Mol Biol. 1974 Jan 15;82(2):175–183. doi: 10.1016/0022-2836(74)90339-8. [DOI] [PubMed] [Google Scholar]
  22. Hand R., Tamm I. Reovirus: effect of noninfective viral components on cellular deoxyribonucleic acid synthesis. J Virol. 1973 Feb;11(2):223–231. doi: 10.1128/jvi.11.2.223-231.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hunter R. Standardization of the chloramine-T method of protein iodination. Proc Soc Exp Biol Med. 1970 Mar;133(3):989–992. doi: 10.3181/00379727-133-34611. [DOI] [PubMed] [Google Scholar]
  24. Klotz I. M. Numbers of receptor sites from Scatchard graphs: facts and fantasies. Science. 1982 Sep 24;217(4566):1247–1249. doi: 10.1126/science.6287580. [DOI] [PubMed] [Google Scholar]
  25. Lai M. H., Joklik W. K. The induction of interferon by temperature-sensitive mutants of reovirus, UV-irradiated reovirus, and subviral reovirus particles. Virology. 1973 Jan;51(1):191–204. doi: 10.1016/0042-6822(73)90379-6. [DOI] [PubMed] [Google Scholar]
  26. Nepom J. T., Weiner H. L., Dichter M. A., Tardieu M., Spriggs D. R., Gramm C. F., Powers M. L., Fields B. N., Greene M. I. Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med. 1982 Jan 1;155(1):155–167. doi: 10.1084/jem.155.1.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Noseworthy J. H., Fields B. N., Dichter M. A., Sobotka C., Pizer E., Perry L. L., Nepom J. T., Greene M. I. Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus. J Immunol. 1983 Nov;131(5):2533–2538. [PubMed] [Google Scholar]
  28. Ramig R. F., Cross R. K., Fields B. N. Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3. J Virol. 1977 Jun;22(3):726–733. doi: 10.1128/jvi.22.3.726-733.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sharpe A. H., Fields B. N. Reovirus inhibition of cellular DNA synthesis: role of the S1 gene. J Virol. 1981 Apr;38(1):389–392. doi: 10.1128/jvi.38.1.389-392.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sharpe A. H., Fields B. N. Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology. 1982 Oct 30;122(2):381–391. doi: 10.1016/0042-6822(82)90237-9. [DOI] [PubMed] [Google Scholar]
  31. Shaw J. E., Cox D. C. Early inhibition of cellular DNA synthesis by high multiplicities of infectious and UV-inactivated Reovirus. J Virol. 1973 Oct;12(4):704–710. doi: 10.1128/jvi.12.4.704-710.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shelton I. H., Kasupski G. J., Jr, Oblin C., Hand R. DNA binding of a nonstructural reovirus protein. Can J Biochem. 1981 Feb;59(2):122–130. doi: 10.1139/o81-018. [DOI] [PubMed] [Google Scholar]
  33. Sturzenbecker L. J., Nibert M., Furlong D., Fields B. N. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol. 1987 Aug;61(8):2351–2361. doi: 10.1128/jvi.61.8.2351-2361.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wassermann N. H., Penn A. S., Freimuth P. I., Treptow N., Wentzel S., Cleveland W. L., Erlanger B. F. Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4810–4814. doi: 10.1073/pnas.79.15.4810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weiner H. L., Ault K. A., Fields B. N. Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol. 1980 May;124(5):2143–2148. [PubMed] [Google Scholar]
  36. Weiner H. L., Drayna D., Averill D. R., Jr, Fields B. N. Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5744–5748. doi: 10.1073/pnas.74.12.5744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Weiner H. L., Fields B. N. Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med. 1977 Nov 1;146(5):1305–1310. doi: 10.1084/jem.146.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Weiner H. L., Powers M. L., Fields B. N. Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis. 1980 May;141(5):609–616. doi: 10.1093/infdis/141.5.609. [DOI] [PubMed] [Google Scholar]
  39. Weiner H. L., Ramig R. F., Mustoe T. A., Fields B. N. Identification of the gene coding for the hemagglutinin of reovirus. Virology. 1978 May 15;86(2):581–584. doi: 10.1016/0042-6822(78)90099-5. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES